You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Crenolanib

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Ulm (chemo (Mitoxantrone, Cytarabine), Placebo, Crenolanib)

Terminated
  • Acute Myeloid Leukemia
  • chemotherapy (Mitoxantrone, Cytarabine)
  • +3 more
  • Ulm, Germany
    Ulm University Hospital
Sep 28, 2021

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate)

Unknown status
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • Houston, Texas
    MD Anderson Cancer Center
Dec 28, 2020

GIST With D842V Mutated PDGFRA Gene Trial in Worldwide (Crenolanib, Placebo)

Active, not recruiting
  • GIST With D842V Mutated PDGFRA Gene
  • Crenolanib
  • Placebo
  • Santa Monica, California
  • +22 more
Jan 21, 2021

Recurrent/Refractory Glioblastoma Trial in Houston (crenolanib)

Completed
  • Recurrent/Refractory Glioblastoma
  • crenolanib
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Esophagogastric Adenocarcinoma Trial in New York (Crenolanib, Ramucirumab, Paclitaxel)

Completed
  • Esophagogastric Adenocarcinoma
  • Crenolanib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 17, 2020

Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies

Completed
  • Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies
  • Crenolanib besylate
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Trial in Worldwide (Crenolanib, Cytarabine,

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
  • Crenolanib
  • +6 more
  • Sacramento, California
  • +61 more
Apr 28, 2021

FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

Available
  • FLT3-ITD Mutation
  • +3 more
  • Crenolanib besylate
  • Genova, Italy
    Ospedale Policlinico San Martino
May 21, 2020

Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)

Completed
  • Newly Diagnosed AML With FLT3 Activating Mutations
  • crenolanib
  • +3 more
  • Duarte, California
  • +8 more
Jul 17, 2020

Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)

Recruiting
  • Newly Diagnosed FLT3 Mutated AML
  • Crenolanib
  • +3 more
  • Duarte, California
  • +30 more
May 21, 2020

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in United States (Crenolanib, Mitoxantrone, Cytarabine)

Completed
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Crenolanib
  • +6 more
  • Little Rock, Arkansas
  • +3 more
May 8, 2019

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Relapsed/Refractory FLT3-mutated AML Trial (Crenolanib, Fludarabine, Cytarabine)

Withdrawn
  • Relapsed/Refractory FLT3-mutated AML
  • Crenolanib
  • +2 more
  • (no location specified)
Jan 8, 2019

Glioma Trial in Dallas (Crenolanib (CP-868,596))

Terminated
  • Glioma
  • Crenolanib (CP-868,596)
  • Dallas, Texas
    Harold Simmons Comprehensive Cancer Center, University of Texas
Jul 2, 2018

Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +9 more
Mar 4, 2022

Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Trial in Dallas (Crenolanib Besylate

Completed
  • Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
  • Crenolanib Besylate (CP-868,596-26)
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jun 26, 2018

D842-related Mutant GIST Trial in Portland, Philadelphia (Crenolanib besylate (CP-868,596-26), Dose: 140mg BID)

Completed
  • D842-related Mutant GIST
  • Crenolanib besylate (CP-868,596-26), Dose: 140mg BID
  • Portland, Oregon
  • +1 more
Jun 26, 2018

Acute Myeloid Leukemia Trial in Memphis (Crenolanib, Sorafenib, methotrexate, hydrocortisone and cytarabine with leucovorin)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib
  • +2 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 2, 2017

Diffuse Intrinsic Pontine Glioma, Progressive or Refractory High-Grade Glioma Trial in Memphis (Crenolanib)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • Progressive or Refractory High-Grade Glioma
  • Crenolanib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 24, 2017

Leukemia, FLT3-Mutated Acute Myeloid Leukemia, FLT3-Mutated High-Risk Myelodysplastic Syndrome Trial (Ponatinib, 5-azacytidine,

Withdrawn
  • Leukemia
  • +2 more
  • (no location specified)
Jun 1, 2017

NSCLC Trial (docetaxel, CP-868,596 + docetaxel, AG-013736 + docetaxel)

Withdrawn
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 7, 2012

Advanced Solid Tumors Trial in Durham, East Melbourne (CP-868,596, Docetaxel, AG-013736)

Completed
  • Advanced Solid Tumors
  • Durham, North Carolina
  • +1 more
Jan 18, 2012